BioNTech is Moving From Germany: Ozlem Tureci and Ugur Sahin Are Moving the Company
Developing the first corona virus vaccine, Prof. Dr. Uğur Şahin and Prof. Dr. Özlem Türeci decided to move their company, BioNTech, from Germany. While the bilateral R&D phase progressed faster, they preferred the UK, while the news in the German press criticized the heavy bureaucracy in the country.
Bild, one of Germany’s leading press organizations, included a news criticizing the Berlin administration and the bureaucracy in the country.
In recent years, it is claimed that many companies left Germany due to slowness in research and development processes and bureaucratic obstacles.
The last company that was the subject of Bild’s news was BioNTecH, which developed the corona virus vaccine. prof. Özlem Türeci and Prof. Dr. Uğur Şahin’s company, BioNTech, which conducts mRNA studies, developed the first Covid-19 vaccine and became a worldwide brand.
BioNTech is Moving
The couple, who also received the “Paul-Ehrlich and Ludwig Darmstaedter 2022” award, which is considered one of the most important awards in the medical world in Germany, decided to move the company’s activities to England. In the UK there is a closer relationship between drug development companies and authorities, so problems are faster. has been exceeded.
Speaking on the subject, Prof. Dr. Türeci said that “the introduction of biotechnology ecosystems in Europe and the relevant regulations and directives and their implementation by funding research more quickly” were effective in their decision, Türeci said.
BioNTech is Moving
It was stated that medical giants such as Bayer are also considering moving their pharmaceutical industries to countries such as the USA and China. It was pointed out that the chemical giant BASF has also established a new factory in China and that approximately 40,000 workers are in danger in Ludwigshafen.